Odonate (Odonate) EBIT per Share : $-22,974.75 (TTM As of Sep. 2021)

View and export this data going back to 2017. Start your Free Trial

What is Odonate EBIT per Share?

Odonate's EBIT per Share for the three months ended in Sep. 2021 was $-1,018.75. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2021 was $-22,974.75.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Odonate's EBIT per Share or its related term are showing as below:

ODTC's 3-Year EBIT Growth Rate is not ranked ^*
in the Diversified Financial Services industry.
Industry Median: 9.65
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Odonate's EBIT for the three months ended in Sep. 2021 was $-4.08 Mil.

Odonate EBIT per Share Historical Data

The historical data trend for Odonate's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Odonate EBIT per Share Chart

Odonate Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

EBIT per Share

Get a 7-Day Free Trial

-1,028.33

-32,744.00

-45,382.00

-38,310.00

-42,477.67

Odonate Quarterly Data
	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21
EBIT per Share	Get a 7-Day Free Trial															-10,216.67	-8,108.50	-8,450.25	-5,397.25	-1,018.75

Odonate EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Odonate's EBIT per Share for the fiscal year that ended in Dec. 2020 is calculated as

	EBIT per Share		(A: Dec. 2020 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-127.433	/	0.003
=	-42,477.67

Odonate's EBIT per Share for the quarter that ended in Sep. 2021 is calculated as

	EBIT per Share		(Q: Sep. 2021 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-4.075	/	0.004
=	-1,018.75

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-22,974.75

Odonate (OTCPK:ODTC) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Odonate EBIT per Share Related Terms

Thank you for viewing the detailed overview of Odonate's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Odonate (Odonate) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Odonate Inc (OTCPK:ODTC) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

3 East 28th Street, 10th Floor, New York, NY, USA, 10016

Website

https://www.odonate.com

Odonate Inc is a Shell company.

Executives

Ecor1 Capital, Llc	10 percent owner	357 TEHAMA STREET #3, SAN FRANCISCO CA 94103
Boxer Capital, Llc	director, 10 percent owner	12860 EL CAMINO REAL, SUITE 300, SAN DIEGO CA 92130
Kevin C Tang	director, 10 percent owner, officer: Chief Executive Officer	4747 EXECUTIVE DRIVE, SUITE 210, SAN DIEGO CA 92121
Aaron I. Davis	director, 10 percent owner	12860 EL CAMINO REAL, SUITE 300, SAN DIEGO CA 92130
Craig A Johnson	director	C/O PURE BIOSCIENCE, 1725 GILLESPIE WAY, EL CAJON CA 92020
Jeff L Vacirca	director	4747 EXECUTIVE DRIVE, SUITE 510, SAN DIEGO CA 92121
Laura L. Johnson	director	C/O LA JOLLA PHARMACEUTICAL COMPANY, LA JOLLA VILLAGE DRIVE, SUITE 1070, SAN DIEGO CA 92122
Michael S Hearne	officer: Chief Financial Officer	4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Joseph P O'connell	officer: Chief Medical Officer	4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Boxer Asset Management Inc.	10 percent owner	CAY HOUSE, EP TAYLOR DRIVE N7776, LYFORD CAY, NEW PROVIDENCE C5 00000
Robert Rosen	director	C/O HERON THERAPEUTICS, INC, 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO CA 92121
Joseph Lewis	10 percent owner	PO BOX N7776, LYFORD BAHAMAS
Tang Capital Management Llc	10 percent owner	4747 EXECUTIVE DRIVE, SUITE 210, SAN DIEGO CA 92121
Tang Capital Partners Lp	10 percent owner	4747 EXECUTIVE DRIVE, SUITE 210, SAN DIEGO CA 92121
John G Lemkey	officer: Chief Financial Officer	4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121